These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30120623)

  • 1. Enhancing Mitochondrial Health to Treat Hypertension.
    Eirin A; Lerman A; Lerman LO
    Curr Hypertens Rep; 2018 Aug; 20(10):89. PubMed ID: 30120623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From mitochondria to disease: role of the renin-angiotensin system.
    de Cavanagh EM; Inserra F; Ferder M; Ferder L
    Am J Nephrol; 2007; 27(6):545-53. PubMed ID: 17785964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage.
    Eirin A; Lerman A; Lerman LO
    Eur Heart J; 2014 Dec; 35(46):3258-66. PubMed ID: 25385092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress.
    Rubattu S; Pagliaro B; Pierelli G; Santolamazza C; Castro SD; Mennuni S; Volpe M
    Int J Mol Sci; 2014 Dec; 16(1):823-39. PubMed ID: 25561233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases.
    Babizhayev MA; Yegorov YE
    Am J Ther; 2016; 23(1):e98-117. PubMed ID: 21048433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines.
    Zhao K; Luo G; Giannelli S; Szeto HH
    Biochem Pharmacol; 2005 Dec; 70(12):1796-806. PubMed ID: 16216225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
    Bavishi C; Bangalore S; Messerli FH
    Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
    Touyz RM
    Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of mitochondrial oxidative stress to hypertension.
    Dikalov SI; Dikalova AE
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):73-80. PubMed ID: 26717313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Transient Receptor Potential Melastatin Subtype 8 Attenuates Cold-Induced Hypertension Through Ameliorating Vascular Mitochondrial Dysfunction.
    Xiong S; Wang B; Lin S; Zhang H; Li Y; Wei X; Cui Y; Wei X; Lu Z; Gao P; Li L; Zhao Z; Liu D; Zhu Z
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28768647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
    de Cavanagh EM; Inserra F; Ferder L
    Cardiovasc Res; 2011 Jan; 89(1):31-40. PubMed ID: 20819950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
    De Cavanagh EM; Toblli JE; Ferder L; Piotrkowski B; Stella I; Fraga CG; Inserra F
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):573-8. PubMed ID: 16309582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.
    Düsing R
    Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):151-61. PubMed ID: 27122491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions of vasoactive systems in cardiovascular damage.
    Bader M
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S7-9. PubMed ID: 11811382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
    Lambers Heerspink HJ; Perkovic V; de Zeeuw D
    J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria in vascular health and disease.
    Dromparis P; Michelakis ED
    Annu Rev Physiol; 2013; 75():95-126. PubMed ID: 23157555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting mitochondria.
    Hoye AT; Davoren JE; Wipf P; Fink MP; Kagan VE
    Acc Chem Res; 2008 Jan; 41(1):87-97. PubMed ID: 18193822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of angiotensin blockade in the management of cardiovascular disease.
    Nantel P; René de Cotret P
    Can J Cardiol; 2010 Dec; 26 Suppl E():7E-13E. PubMed ID: 21620285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.